Home › Kanser sa Prostate › West Virginia
Pag-aaral pangklinika para sa Kanser sa Prostate sa West Virginia
6 pag-aaral para sa Kanser sa Prostate ang naghahanap ng mga kalahok sa mga site sa West Virginia.
Mga Lungsod sa West Virginia
Opisyal na teksto ng pag-aaral (English)
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Vandalia Health/CAMC Institute for Academic Medicine, Charleston
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 2, 2026 · NCT06931340Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Edwards Comprehensive Cancer Center, Huntington
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Edwards Comprehensive Cancer Center, Huntington
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06632977Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Edwards Comprehensive Cancer Center, Huntington
- West Virginia University Healthcare, Morgantown
- Camden Clark Medical Center, Parkersburg
- at 1 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Set 10, 2026 · NCT05946213SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Morgantown
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- West Virginia University Healthcare, Morgantown
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Set 11, 2025 · NCT03678025Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.